<span item_type="fundamental" item_id="ceaa064b1a8b8ef330e90f60363b591d" counter_id="ST/US/LEXXW" env="prod"></span><span item_type="announcement" item_id="538106814961095425" env="prod"></span><p>营收：截至 2025 财年 Q3，公布值为 53.19 万美元。</p><p>每股收益：截至 2025 财年 Q3，公布值为 -0.53 美元。</p><p></p><h3>财务指标按部门划分</h3><h4>收入</h4><ul><li><strong>IP Licensing</strong>: 收入为 $522,000。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li><li><strong>B2B 产品</strong>: 收入为 $9,923。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li><li><strong>合计</strong>: 总收入为 $531,923。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li></ul><h4>营运费用</h4><ul><li><strong>研发费用</strong>: 研发费用为 $6,356,637。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li><li><strong>总营运费用</strong>: 总营运费用为 $9,721,343。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li></ul><h4>其他收入（损失）</h4><ul><li><strong>其他收入（损失）</strong>: 为 - $22,066。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li></ul><h4>现金流</h4><ul><li><strong>经营活动现金流</strong>: 经营活动使用的现金为 - $7,807,889。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li><li><strong>投资活动现金流</strong>: 投资活动使用的现金为 - $85,141。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li><li><strong>融资活动现金流</strong>: 融资活动提供的现金为 $6,046,163。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li></ul><h4>未来展望和策略</h4><ul><li><strong>核心业务重点</strong>: 公司计划继续推进 DehydraTECH 技术在 GLP-1/GIP 药物和 CBD 治疗糖尿病和减肥方面的研发。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li><li><strong>非核心业务</strong>: 公司可能会通过与第三方的许可协议、合作、伙伴关系、联盟营销、分销或许可安排来增加资本资源。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li></ul><h4>经营亏损</h4><ul><li><strong>净亏损</strong>: 净亏损为 - $9,214,206。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li></ul><h4>资产总计</h4><ul><li><strong>总资产</strong>: 总资产为 $6,741,366。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li></ul>

LEXARIA BIOSCIENCE CORP C/WTS 14/01/2026 (TO PUR COM)｜10-Q：2025 财年 Q3 营收 53.19 万美元